1. Home
  2. ASH vs WVE Comparison

ASH vs WVE Comparison

Compare ASH & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ashland Inc.

ASH

Ashland Inc.

HOLD

Current Price

$62.24

Market Cap

2.9B

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$13.67

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASH
WVE
Founded
1924
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ASH
WVE
Price
$62.24
$13.67
Analyst Decision
Buy
Strong Buy
Analyst Count
8
16
Target Price
$66.29
$30.56
AVG Volume (30 Days)
673.3K
3.8M
Earning Date
02-02-2026
03-03-2026
Dividend Yield
2.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,805,000,000.00
$109,230,000.00
Revenue This Year
$3.34
N/A
Revenue Next Year
$3.55
$16.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
103.75
52 Week Low
$45.21
$5.28
52 Week High
$67.39
$21.73

Technical Indicators

Market Signals
Indicator
ASH
WVE
Relative Strength Index (RSI) 52.66 48.95
Support Level $57.87 $12.70
Resistance Level $64.55 $14.56
Average True Range (ATR) 1.97 0.78
MACD -0.12 -0.02
Stochastic Oscillator 59.42 53.73

Price Performance

Historical Comparison
ASH
WVE

About ASH Ashland Inc.

Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: